title: Human hepatic preservation using Marshall's solution and University of Wisconsin solution in a controlled, prospective trial.
authors.affiliation: Liver Unit, Queen Elizabeth Hospital, Birmingham, England.
authors.forename: I L
authors.initials: IL
authors.lastname: Badger
authors.forename: I D
authors.initials: ID
authors.lastname: Michell
authors.forename: L J
authors.initials: LJ
authors.lastname: Buist
authors.forename: D
authors.initials: D
authors.lastname: Sherlock
authors.forename: J A
authors.initials: JA
authors.lastname: Buckels
authors.forename: P
authors.initials: P
authors.lastname: McMaster
mesh_terms: D000241:Adenosine; D000493:Allopurinol; D002648:Child; D005978:Glutathione; D006801:Humans; D006982:Hypertonic Solutions; D007165:Immunosuppression Therapy; D007328:Insulin; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology*; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011446:Prospective Studies; D011887:Raffinose; D012996:Solutions; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D006982:Hypertonic Solutions; D007328:Insulin; C054581:Marshall's citrate solution; D019188:Organ Preservation Solutions; D012996:Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose